Strategic Advisory Board

The Strategic Advisory Board is a consultative body that provides independent guidance on the Foundation’s long-term vision, strategic priorities, and institutional development. Its main mission is to advise the Governing Board on key opportunities and challenges related to research innovation, partnerships, global positioning, and sustainable growth, supporting the Foundation in advancing its mission and future impact.

Membership of the Strategic Advisory Board

PositionName / AffiliationYear appointment
ChairJonel Trebicka
EF CLIF, Spain
2025
SecretarySalvatore Piano
University of Padova, Italy
2025
Appointed membersSalvador Augustin
Boehringer Ingelheim
2025
Julia Doerner
Boehringer Ingelheim
2025
Tom H. Karlsen
University of Oslo
2025
Percy Knolle
Technische Universität München
2025
Pejvack Motlagh
GENFIT
2025
Valerie Paradis
Assistance Publique– Hôpitaux de Paris
2025
Sakina Sayah-Jeanne
GENFIT
2025
Joerg Schuettrumpf
Grifols
2025
Debbie Shawcross
European Association for the Study of the Liver
2025

Richard Moreau

Chair
European Foundation for the Study of Chronic Liver Failure, Spain

Jonel Trebicka

Secretary
European Foundation for the Study of Chronic Liver Failure, Spain

Jean-Charles Nault

Hôpital Avicenne, France
Cordeliers Research Center, University of Paris, INSERM UMR 1138, France

Luca Valenti

University of Milan, Italy

Frank Tacke

Charité–Universitätsmedizin Berlin, Germany

Sophie Lotersztain

Center for Research in Inflammation, University of Paris, INSERM U1149, France

Eric Trépo

CUB Hôpital Erasme–Université Libre de Bruxelles, Belgium

Paolo Caraceni

University of Bologna, Italy

Mala K. Maini

University College London, United Kingdom

José María Mato

CICbioGUNE, Spain

Tom Hemming Karlsen

University of Oslo, Norway

Helena Cortez-Pinto

University of Lisbon, Portugal

Jessica Zucman-Rossi

Cordeliers Research Center, University of Paris, INSERM UMR 1138, France

Guliana Magri

Hospital del Mar Research Institute, Spain